Fundraising FoxAAIC — Full Portfolio
5 tracked investments · listed companies and verified rows first
Aumet builds an AI-driven procurement and ERP platform for the pharmaceutical supply chain, connecting pharmacies, drug manufacturers, distributors, hospitals, and health ministries with tools for sourcing, pricing, and inventory visibility.
AI & Machine LearningB2B MarketplacesHealthtechSaaSAmman, US
Ashraf SamhouriMohamed BatterjiTariq KhaderinYahya Aqel(Founder)Shahed Jaber(Founder)inAdel Haddadin
Co-investors500 GlobalShorooq PartnersTechstarsRSCMAsia Africa Investment & Consulting (AAIC)Plug and Play Ventures+5 more
CrowdForce operates a mobile app enabling small merchants across Africa to function as banking service points without establishing formal branch infrastructure.
FintechGovTechAbuja, NG
Oluwatomi Ayorinde(Founder)inDamilola Ayorinde(Founder)inTomi Ayorinde(Founder)
Co-investors500 GlobalAsia Africa Investment & Consulting (AAIC)HAVAICMAGIC FundVentures PlatformY Combinator+5 more
End-to-end procurement platform giving hospitals and pharmacies access to genuine pharmaceutical products.
Adham Yehia(Founder)in
Co-investorsAsia Africa Investment & Consulting (AAIC)Co-Creation Hub (CcHUB)VestedWorld
Pan-African eyewear brand expanding access to affordable eye care across 10 countries with 134+ stores.
Co-investorsAsia Africa Investment & Consulting (AAIC)Beyond Capital VenturesEQ2 VenturesSaviu VenturesAfricInvestFINCA Ventures+1 more
Reliance Health provides healthcare services combining medical expertise with technology for individuals and corporate customers in growing economies.
Digital HealthHealthtechInsurTechLagos, NG
Femi Kuti(CEO)inMatthew Mayaki(Senior Vice President Product)inOpeyemi Olumekun(COO)inAdebayo Aderohunmu(Recruitment Associate)Joshua Banye(Vice President, People Operations)Leye Odumuyiwa(Engineer Manager)
Co-investorsAsia Africa Investment & Consulting (AAIC)General AtlanticLaerdal Million Lives FundLoftyInc CapitalP1 VenturesPartech Ventures+15 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.